Impacts of COVID-19
|
Pandemic insights (new sub-section)
|
Pandemic insights into Australian smokers, 2020-21 (ABS NHS)
|
Purchase and consumption of AOD: ABS Household Impacts of COVID-19 Survey; Wastewater analysis; EDRS; IDRS
|
Household Impacts of COVID-19 Survey
National Wastewater Drug Monitoring Program Report 15
Australian Drug Trends 2021: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews
Australian Drug Trends 2021: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews
|
Section 2: Data by region
|
Drug-induced deaths
|
AIHW analysis of National Mortality Database
|
Section 3: Harm minimisation
|
Demand reduction
|
Alcohol and other drug treatment services in Australia: early insights 2020-21
|
Supply reduction: Wastewater analysis
|
National Wastewater Drug Monitoring Program Report 15
|
Section 4: Impacts
|
Health impacts: Drug-induced deaths
|
AIHW analysis of National Mortality Database
|
Health Impacts: Burden of disease
|
Australian Burden of Disease Study: impact and causes of illness and death in Aboriginal and Torres Strait Islander people 2018
|
Social impacts: Homicide
|
Homicide in Australia 2019–20
|
Economic impacts: Social costs
|
Examining the Social and Economic Costs of Alcohol Use in Australia: 2017/18
|
Section 5: Drug Types
|
Tobacco: Consumption; Treatment
|
National Wastewater Drug Monitoring Program, Report 15
ABS National Health Survey
Alcohol and other drug treatment services in Australia: early insights
|
Alcohol: Consumption; Harms; Treatment
|
National Wastewater Drug Monitoring Program, Report 15
AIHW analysis of National Mortality Database
Alcohol and other drug treatment services in Australia: early insights
|
Cannabis: Consumption; Harms; Treatment
|
National Wastewater Drug Monitoring Program, Report 15
AIHW analysis of National Mortality Database
Alcohol and other drug treatment services in Australia: early insights
|
Meth/amphetamine and other stimulants: Consumption; Harms; Treatment
|
National Wastewater Drug Monitoring Program, Report 15
AIHW analysis of National Mortality Database
Alcohol and other drug treatment services in Australia: early insights
|
Non-medical use of pharmaceuticals: Consumption; Harms; Treatment
|
National Wastewater Drug Monitoring Program, Report 15
AIHW analysis of National Mortality Database
Alcohol and other drug treatment services in Australia: early insights
|
Illicit opioids, including heroin: Consumption; Harms; Treatment
|
National Wastewater Drug Monitoring Program, Report 15
AIHW analysis of National Mortality Database
Alcohol and other drug treatment services in Australia: early insights
National Opioid Pharmacotherapy Statistics Annual Data Collection
|
New psychoactive substances (NPS): Consumption
|
National Wastewater Drug Monitoring Program, Report 15
|
Section 6: Priority populations
|
Aboriginal and Torres Strait Islander people: Tobacco smoking; Alcohol consumption; Illicit drugs; Health and harms; Treatment
|
Australian Burden of Disease Study: impact and causes of illness and death in Aboriginal and Torres Strait Islander people 2018
Alcohol and other drug treatment services in Australia: early insights
National Opioid Pharmacotherapy Statistics Annual Data Collection
|
Older people: Health and harms; Treatment
|
AIHW analysis of National Mortality Database
Alcohol and other drug treatment services in Australia: early insights
National Opioid Pharmacotherapy Statistics Annual Data Collection
|
People from culturally and linguistically diverse backgrounds: Treatment
|
Alcohol and other drug treatment services in Australia: early insights
|
People in contact with the criminal justice system: Police; Courts; Corrective Services; Young people under youth supervision; Illicit Drugs
|
ABS Recorded Crime – Offenders, 2020–21
ABS Criminal Courts Australia, 2020–21
Prisoners in Australia 2021
|
Younger people: Health and harms; Treatment
|
AIHW analysis of National Mortality Database
Alcohol and other drug treatment services in Australia: early insights
|